Telecoms Today
SEE OTHER BRANDS

Catch up with telecommunications news from the world

Telecoms Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Telecoms Today.

Press releases published on August 27, 2025

NVIDIA Announces Financial Results for Second Quarter Fiscal 2026

NVIDIA Announces Financial Results for Second Quarter Fiscal 2026

Revenue of $46.7 billion, up 6% from Q1 and up 56% from a year ago Data Center revenue of $41.1 billion, up 5% from Q1 and up 56% from a year ago Blackwell Data Center revenue grew 17% sequentially SANTA CLARA, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- …

Kirby McInerney LLP Reminds Replimune Group, Inc. Investors of Class Action Filing and Encourages Investors to Contact the Firm

Kirby McInerney LLP Reminds Replimune Group, Inc. Investors of Class Action Filing and Encourages Investors to Contact the Firm

NEW YORK, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Kirby McInerney LLP reminds investors who purchased Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) securities to contact Thomas W. Elrod of Kirby McInerney LLP by email at investigations@ …

Calian Reaffirms Strategic Direction and Commitment to Long-Term Shareholder Value

Calian Reaffirms Strategic Direction and Commitment to Long-Term Shareholder Value

OTTAWA, Ontario, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Calian® Group Ltd. (“Calian” or the “Company”) (TSX:CGY) (TSX:CGY), a mission-critical solutions company focused on defence, space, healthcare and other strategic critical infrastructure sectors, …

Supernus Pharmaceuticals to Participate in September Investor Conferences

Supernus Pharmaceuticals to Participate in September Investor Conferences

ROCKVILLE, Md., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a biopharmaceutical company focused on developing and commercializing products for the treatment of central nervous system (CNS) diseases, announced today …

Invitation to Martin Marietta’s Capital Markets Day on September 3, 2025

Invitation to Martin Marietta’s Capital Markets Day on September 3, 2025

RALEIGH, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Martin Marietta Materials, Inc. (NYSE: MLM) (Martin Marietta or the Company), a leading national supplier of aggregates and heavy building materials, invites investors and analysts to the live broadcast of …

Anaptys Announces Participation in September Investor Conferences

Anaptys Announces Participation in September Investor Conferences

SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a clinical-stage biotechnology company focused on delivering innovative immunology therapeutics, today announced that Daniel Faga, president and chief executive officer of …

Synergy CHC Corp. Announces the Closing of its $4.375 Million Public Offering

Synergy CHC Corp. Announces the Closing of its $4.375 Million Public Offering

WESTBROOK, Maine, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Synergy CHC Corp. (Nasdaq: SNYR) (“Synergy” or the “Company”), a leading consumer health and wellness company, today announced the closing of an underwritten public offering of 1,750,000 shares of common …

Bespoke Extracts, Inc. Announces Financial Results for the Second Quarter ended June 30, 2025

Bespoke Extracts, Inc. Announces Financial Results for the Second Quarter ended June 30, 2025

AURORA, Colo., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Bespoke Extracts, Inc. (“Bespoke” or the “Company”) (OTCQB: BSPK), today reported its financial results for the quarter ended June 30, 2025. Financial results are reported in accordance with U.S. generally …

Aardvark Therapeutics to Present at Upcoming Investor Conferences in September

Aardvark Therapeutics to Present at Upcoming Investor Conferences in September

SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Aardvark Therapeutics, Inc. (Aardvark) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate homeostatic pathways for the …

Acarpia Farmaceutici and EarlyHealth Group Expand Their Partnership to Improve Access in CARICOM and Mexico

Acarpia Farmaceutici and EarlyHealth Group Expand Their Partnership to Improve Access in CARICOM and Mexico

MILAN, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Acarpia Farmaceutici S.r.l., an Italian pharmaceutical manufacturer, and EarlyHealth Group, a global pharmaceutical service provider, have announced the expansion of their strategic partnership to improve access to …

Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

Adaptive Biotechnologies to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference

SEATTLE, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Adaptive Biotechnologies Corporation (Nasdaq: ADPT), a commercial stage biotechnology company that aims to translate the genetics of the adaptive immune system into clinical products to diagnose and treat disease, …

MannKind to Present at Upcoming Investor Conferences

MannKind to Present at Upcoming Investor Conferences

DANBURY, Conn. and WESTLAKE VILLAGE, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of innovative inhaled therapeutic products and devices for patients with …

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

ORIC® Pharmaceuticals to Participate in Upcoming Investor Conferences

SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Aug. 27, 2025 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced …

Andrew Ross Joins Symbotic’s Board of Directors

Andrew Ross Joins Symbotic’s Board of Directors

WILMINGTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Symbotic Inc. (Nasdaq: SYM), a leader in A.I.-enabled robotics technology for the supply chain, today announced the election of Andrew (“Andy”) Ross to its Board of Directors, effective August 26, 2025. …

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

Myriad Genetics to Participate in Upcoming Investor Healthcare Conferences

SALT LAKE CITY, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc. (NASDAQ: MYGN), a leader in molecular diagnostic testing and precision medicine, today announced Myriad management will participate in two upcoming healthcare conferences. The Wells …

Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025

Sanara MedTech Inc. to Present at the Cantor Global Healthcare Conference on September 3, 2025

FORT WORTH, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Sanara MedTech Inc. (“Sanara,” the “Company,” “we,” “our” or “us”) (Nasdaq: SMTI), a medical technology company focused on developing and commercializing transformative technologies to improve clinical …

HP Inc. Reports Fiscal 2025 Third Quarter Results

HP Inc. Reports Fiscal 2025 Third Quarter Results

PALO ALTO, Calif., Aug. 27, 2025 (GLOBE NEWSWIRE) -- HP (NYSE: HPQ) Third quarter GAAP diluted net earnings per share ("EPS") of $0.80, up 23.1% from the prior year period Third quarter non-GAAP diluted net EPS of $0.75, down 10.7% from the prior year …

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September

Organogenesis Holdings Inc. to Participate in Upcoming Investor Conferences in September

CANTON, Mass., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Organogenesis Holdings Inc. (Nasdaq: ORGO), a leading regenerative medicine company focused on the development, manufacture, and commercialization of product solutions for the Advanced Wound Care and …

Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program

Celcuity to Initiate NDA Submission of Gedatolisib in PIK3CA Wild-Type Cohort in HR+/HER2- Advanced Breast Cancer Under FDA’s Real-Time Oncology Review Program

MINNEAPOLIS, Aug. 27, 2025 (GLOBE NEWSWIRE) -- Celcuity Inc. (Nasdaq: CELC), a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced the U.S. Food and Drug Administration (“FDA”) agreed to accept its …

MDB Capital Holdings Provides Second Quarter 2025 Update

MDB Capital Holdings Provides Second Quarter 2025 Update

Addison, TX, Aug. 27, 2025 (GLOBE NEWSWIRE) -- MDB Capital Holdings, LLC, (NASDAQ: MDBH) (“MDB”), a public venture platform focused on launching category-leading “Big Idea” companies, today provides an operational update for the quarter ended June 30, 2025 …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions